GSK Appoints Brian McNamara as CEO Designate of New Independent Consumer Healthcare Company

The Board of GSK (GSK) announced that Brian McNamara, the CEO of GSK Consumer Healthcare (a Joint Venture between GSK and Pfizer) has been appointed as CEO Designate of the new, listed Consumer Healthcare company which will result from the proposed demerger of Consumer Healthcare from GSK in 2022. 

The company will be a new world leader in Consumer Health with a portfolio that generates annual sales of more than £10 billion in 2020. The company will have a strong portfolio of brands including Sensodyne, Voltaren, Panadol, and Centrum and will hold category leadership positions and major sales presences in the US and China.